{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T15:53:39Z","timestamp":1760889219674},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100006698","name":"School of Pharmacy, Fudan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006698","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Talanta"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.talanta.2016.07.022","type":"journal-article","created":{"date-parts":[[2016,7,9]],"date-time":"2016-07-09T12:26:39Z","timestamp":1468067199000},"page":"256-267","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["The development of a quantitative and qualitative method based on UHPLC-QTOF MS\/MS for evaluation paclitaxel\u2013tetrandrine interaction and its application to a pharmacokinetic study"],"prefix":"10.1016","volume":"160","author":[{"given":"Dan","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhonglian","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueling","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.talanta.2016.07.022_bib1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1021\/mp700119e","article-title":"Understanding tubulin\/microtubule-taxane interactions: a quantitative structure \u2013 activity relationship study","volume":"5","author":"Hansch","year":"2008","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.talanta.2016.07.022_bib2","doi-asserted-by":"crossref","first-page":"794","DOI":"10.2165\/00003495-199448050-00009","article-title":"Paclitaxel \u2013 a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of cancer","volume":"48","author":"Spencer","year":"1994","journal-title":"Drugs"},{"key":"10.1016\/j.talanta.2016.07.022_bib3","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ccell.2015.05.009","article-title":"Inhibition of spleen tyrosine kinase potentiates paclitaxel-induced cytotoxicity in ovarian cancer cells by stabilizing microtubules","volume":"28","author":"Yu","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.talanta.2016.07.022_bib4","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1177\/1078155214556008","article-title":"Abraxane(R) versus Taxol(R) for patients with advanced breast cancer: a prospective time and motion analysis from a Chinese health care perspective","volume":"22","author":"Dranitsaris","year":"2016","journal-title":"J. Oncol. Pharm. Pract."},{"key":"10.1016\/j.talanta.2016.07.022_bib5","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ejca.2015.12.022","article-title":"Is there a role of nab-paclitaxel in the treatment of advanced non-small cell lung cancer? The data suggest yes","volume":"56","author":"Villaruz","year":"2016","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.talanta.2016.07.022_bib6","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.3892\/ijo.2013.2083","article-title":"Establishment and characterization of a paclitaxelresistant human esophageal carcinoma cell line","volume":"43","author":"Wang","year":"2013","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.talanta.2016.07.022_bib7","doi-asserted-by":"crossref","first-page":"9444","DOI":"10.1016\/j.biomaterials.2011.08.041","article-title":"Synergistic effect of folate-mediated targeting and verapamil-mediated P-gp inhibition with paclitaxel-polymer micelles to overcome multi-drug resistance","volume":"32","author":"Wang","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.talanta.2016.07.022_bib8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1023\/B:BREA.0000021046.29834.12","article-title":"Cross-resistance studies of isogenic drug-resistant breast tumor cell lines support recent clinical evidence suggesting that sensitivity to paclitaxel may be strongly compromised by prior doxorubicin exposure","volume":"85","author":"Guo","year":"2004","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.talanta.2016.07.022_bib9","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1158\/1535-7163.MCT-09-0256","article-title":"Evaluation of current methods used to analyze the expression profiles of ATP-binding cassette transporters yields an improved drug-discovery database","volume":"8","author":"Orina","year":"2009","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.talanta.2016.07.022_bib10","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.colsurfb.2016.01.003","article-title":"Novel Soluplus\u00ae\u2014TPGS mixed micelles for encapsulation of paclitaxel with enhanced in vitro cytotoxicity on breast and ovarian cancer cell lines","volume":"140","author":"Bernabeu","year":"2016","journal-title":"Colloid Surf. B."},{"key":"10.1016\/j.talanta.2016.07.022_bib11","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/bjc.1997.530","article-title":"Enhanced oral bioavailability of paclitaxel in mice treated with the P-glycoprotein blocker SDZ PSC 833","volume":"76","author":"van Asperen","year":"1997","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.talanta.2016.07.022_bib12","doi-asserted-by":"crossref","first-page":"e86369","DOI":"10.1371\/journal.pone.0086369","article-title":"Honokiol enhances paclitaxel efficacy in multi-drug resistant human cancer model through the induction of apoptosis","volume":"9","author":"Xu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.talanta.2016.07.022_bib13","first-page":"3459","article-title":"Oral paclitaxel and concurrent cyclosporin a: targeting clinically relevant systemic exposure to paclitaxel","volume":"6","author":"Britten","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.talanta.2016.07.022_bib14","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s10637-015-0236-4","article-title":"Pharmacokinetic drug-drug interaction study of the angiopoietin-1\/angiopoietin-2-inhibiting peptibody trebananib (AMG 386) and paclitaxel in patients with advanced solid tumors","volume":"33","author":"Diamond","year":"2015","journal-title":"Invest. New Drug"},{"key":"10.1016\/j.talanta.2016.07.022_bib15","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/bcp.12368","article-title":"Effects of HM30181, a P-glycoprotein inhibitor, on the pharmacokinetics and pharmacodynamics of loperamide in healthy volunteers","volume":"78","author":"Kim","year":"2014","journal-title":"Br. J. Clin. Pharm."},{"key":"10.1016\/j.talanta.2016.07.022_bib16","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jconrel.2013.09.011","article-title":"Paclitaxel-loaded polymeric microparticles: quantitative relationships between in vitro drug release rate and in vivo pharmacodynamics","volume":"172","author":"Tsai","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.talanta.2016.07.022_bib17","first-page":"4309","article-title":"The preparation, characterization, and pharmacokinetic studies of chitosan nanoparticles loaded with paclitaxel\/dimethyl-beta-cyclodextrin inclusion complexes","volume":"10","author":"Ye","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.talanta.2016.07.022_bib18","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1007\/s00216-014-7684-0","article-title":"Development and validation of a LC\/TOF MS method for the determination of carboplatin and paclitaxel in nanovesicles","volume":"406","author":"Mo","year":"2014","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.talanta.2016.07.022_bib19","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0959-8049(01)00356-2","article-title":"The multidrug resistance of tumour cells was reversed by tetrandrine in vitro and in xenografts derived from human breast adenocarcinoma MCF-7\/adr cells","volume":"38","author":"Fu","year":"2002","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.talanta.2016.07.022_bib20","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00280-003-0742-5","article-title":"Characterization of tetrandrine, a potent inhibitor of P-glycoprotein-mediated multidrug resistance","volume":"53","author":"Fu","year":"2004","journal-title":"Cancer Chemother. Pharm."},{"key":"10.1016\/j.talanta.2016.07.022_bib21","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.phymed.2014.04.029","article-title":"Tetrandrine and fangchinoline, bisbenzylisoquinoline alkaloids from Stephania tetrandra can reverse multidrug resistance by inhibiting P-glycoprotein activity in multidrug resistant human cancer cells","volume":"21","author":"Sun","year":"2014","journal-title":"Phytomedicine"},{"key":"10.1016\/j.talanta.2016.07.022_bib22","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-015-0905-0","article-title":"Tetrandrine reverses drug resistance in isoniazid and ethambutol dual drug-resistant Mycobacterium tuberculosis clinical isolates","volume":"15","author":"Zhang","year":"2015","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.talanta.2016.07.022_bib23","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.leukres.2005.08.005","article-title":"Combination of tetrandrine as a potential-reversing agent with daunorubicin, etoposide and cytarabine for the treatment of refractory and relapsed acute myelogenous leukemia","volume":"30","author":"Xu","year":"2006","journal-title":"Leuk. Res."},{"key":"10.1016\/j.talanta.2016.07.022_bib24","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0024-3205(03)00266-2","article-title":"Tetrandrine-induced cell cycle arrest and apoptosis in Hep G2 cells","volume":"73","author":"Kuo","year":"2003","journal-title":"Life Sci."},{"key":"10.1016\/j.talanta.2016.07.022_bib25","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/j.bcp.2004.01.018","article-title":"Tetrandrine-induced apoptosis is mediated by activation of caspases and PKC-\u03b4 in U937 cells","volume":"67","author":"Jang","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.talanta.2016.07.022_bib26","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1248\/yakushi.128.663","article-title":"Effect of Tetrandrine Combined with Epirubicin on the Growth of Human Breast Carcinoma Multidrug Resistance Cell Line","volume":"128","author":"Hou","year":"2008","journal-title":"Yakugaku Zasshi"},{"key":"10.1016\/j.talanta.2016.07.022_bib27","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00280-007-0416-9","article-title":"Synergistic interaction between tetrandrine and chemotherapeutic agents and influence of tetrandrine on chemotherapeutic agent-associated genes in human gastric cancer cell lines","volume":"60","author":"Wei","year":"2007","journal-title":"Cancer Chemother. Pharm."},{"key":"10.1016\/j.talanta.2016.07.022_bib28","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4142\/jvs.2009.10.1.23","article-title":"Synergistic effect of ERK inhibition on tetrandrine-induced apoptosis in A549 human lung carcinoma cells","volume":"10","author":"Cho","year":"2009","journal-title":"J. Vet. Sci."},{"key":"10.1016\/j.talanta.2016.07.022_bib29","first-page":"1953","article-title":"In vitro and in vivo characterizations of tetrandrine on the reversal of P-glycoprotein-mediated drug resistance to paclitaxel","volume":"25","author":"Zhu","year":"2005","journal-title":"Anticancer Res."},{"key":"10.1016\/j.talanta.2016.07.022_bib30","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s10637-015-0236-4","article-title":"Pharmacokinetic drug-drug interaction study of the angiopoietin-1\/angiopoietin-2-inhibiting peptibody trebananib (AMG 386) and paclitaxel in patients with advanced solid tumors","volume":"33","author":"Diamond","year":"2015","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.talanta.2016.07.022_bib31","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.clinthera.2015.12.009","article-title":"Pharmacokinetics of weekly paclitaxel and feasibility of dexamethasone taper in japanese patients with advanced non\u2013small cell lung cancer","volume":"38","author":"Nokihara","year":"2016","journal-title":"Clin. Ther."},{"key":"10.1016\/j.talanta.2016.07.022_bib32","first-page":"1","article-title":"Effects of Jia-Wei-Xiao-Yao-San on the peripheral and lymphatic pharmacokinetics of paclitaxel in rats","author":"Hou","year":"2016","journal-title":"Evid.-Based Complement. Altern."},{"key":"10.1016\/j.talanta.2016.07.022_bib33","doi-asserted-by":"crossref","first-page":"510","DOI":"10.18632\/oncotarget.2638","article-title":"The small molecule tyrosine kinase inhibitor NVP-BHG712 antagonizes ABCC10-mediated paclitaxel resistance: a preclinical and pharmacokinetic study","volume":"6","author":"Kathawala","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.talanta.2016.07.022_bib34","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.jep.2013.09.054","article-title":"Tetrandrine, an antihypertensive alkaloid, improves the sleep state of spontaneously hypertensive rats (SHRs)","volume":"151","author":"Zhang","year":"2014","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.talanta.2016.07.022_bib35","first-page":"1057","article-title":"Tetrandrine and related bis-benzylisoquinoline alkaloids from medicinal herbs: cardiovascular effects and mechanisms of action","volume":"23","author":"Kwan","year":"2002","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.talanta.2016.07.022_bib36","doi-asserted-by":"crossref","first-page":"H1564","DOI":"10.1152\/ajpheart.00126.2015","article-title":"Tetrandrine reverses human cardiac myofibroblast activation and myocardial fibrosis","volume":"308","author":"Teng","year":"2015","journal-title":"Am. J. Physiol. Heart C"},{"key":"10.1016\/j.talanta.2016.07.022_bib37","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1248\/bpb.b13-00272","article-title":"Tetrandrine potentiates the hypoglycemic efficacy of berberine by inhibiting P-glycoprotein function","volume":"36","author":"Shan","year":"2013","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.talanta.2016.07.022_bib38","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3109\/00498254.2015.1071502","article-title":"Effect of buffer conditions on CYP2C8-mediated paclitaxel 6alpha-hydroxylation and CYP3A4-mediated triazolam alpha- and 4-hydroxylation by human liver microsomes","volume":"46","author":"Kudo","year":"2016","journal-title":"Xenobiotica"},{"key":"10.1016\/j.talanta.2016.07.022_bib39","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s002800050461","article-title":"A convenient tubulin-based quantitative assay for paclitaxel (Taxol) derivatives more effective in inducing assembly than the parent compound","volume":"38","author":"Lin","year":"1996","journal-title":"Cancer Chemother. Pharm."},{"key":"10.1016\/j.talanta.2016.07.022_bib40","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.1021\/ac970233h","article-title":"A receptor protein-based bioassay for quantitative determination of paclitaxel","volume":"69","author":"Suye","year":"1997","journal-title":"Anal. Chem."},{"key":"10.1016\/j.talanta.2016.07.022_bib41","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0021-9673(97)01204-1","article-title":"Determination of a new polymer-bound paclitaxel derivative (PNU 166945), free paclitaxel and 7-epipaclitaxel in dog plasma and urine by reversed-phase high-performance liquid chromatography with UV detection","volume":"797","author":"Fraier","year":"1998","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.talanta.2016.07.022_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-1759(97)00183-X","article-title":"Development of a fluorescence polarization immunoassay (for the quantitative determination of paclitaxel","volume":"212","author":"Bicamumpaka","year":"1998","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.talanta.2016.07.022_bib43","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0026-265X(02)00175-3","article-title":"Electrochemical study of taxol (paclitaxel) by cathodic stripping voltammetry: determination in human urine","volume":"74","author":"Holgado","year":"2003","journal-title":"Microchem. J."},{"key":"10.1016\/j.talanta.2016.07.022_bib44","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1006\/abio.2000.4630","article-title":"Development of a fluorescence immunoassay for measurement of paclitaxel in human plasma","volume":"283","author":"Sheikh","year":"2000","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.talanta.2016.07.022_bib45","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jchromb.2003.08.049","article-title":"Determination of paclitaxel in mouse plasma and brain tissue by liquid chromatography\u2013mass spectrometry","volume":"798","author":"Guo","year":"2003","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.talanta.2016.07.022_bib46","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1002\/rcm.2567","article-title":"Measurement of paclitaxel and its metabolites in human plasma using liquid chromatography\/ion trap mass spectrometry with a sonic spray ionization interface","volume":"20","author":"Green","year":"2006","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.talanta.2016.07.022_bib47","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/chromsci\/44.5.266","article-title":"Determination of paclitaxel in rat plasma by LC-MS-MS","volume":"44","author":"Tong","year":"2006","journal-title":"J. Chromatogr. Sci."},{"key":"10.1016\/j.talanta.2016.07.022_bib48","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jpba.2013.12.028","article-title":"LC\u2013MS\/MS quantitative analysis of paclitaxel and its major metabolites in serum, plasma and tissue from women with ovarian cancer after intraperitoneal chemotherapy","volume":"91","author":"Fern\u00e1ndez-Peralbo","year":"2014","journal-title":"J. Pharm. Biomed."},{"key":"10.1016\/j.talanta.2016.07.022_bib49","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1002\/rcm.2525","article-title":"Liquid chromatography\/tandem triple-quadrupole mass spectrometry for determination of paclitaxel in rat tissues","volume":"20","author":"Tong","year":"2006","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.talanta.2016.07.022_bib50","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ajps.2013.07.026","article-title":"A rapid and sensitive determination of paclitaxel in rat plasma by UPLC-MS\/MS method: application to a pharmacokinetic study","volume":"8","author":"Lian","year":"2013","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.talanta.2016.07.022_bib51","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jchromb.2012.02.003","article-title":"A rapid and sensitive LC\/ESI\u2013MS\/MS method for quantitative analysis of docetaxel in human plasma and its application to a pharmacokinetic study","volume":"893\u2013894","author":"Yamaguchi","year":"2012","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.talanta.2016.07.022_bib52","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1016\/j.jchromb.2011.08.034","article-title":"A sensitive combined assay for the quantification of paclitaxel, docetaxel and ritonavir in human plasma using liquid chromatography coupled with tandem mass spectrometry","volume":"879","author":"Hendrikx","year":"2011","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.talanta.2016.07.022_bib53","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ab.2006.08.032","article-title":"High-resolution characterization of antibody fragment\/antigen interactions using Biacore T100","volume":"359","author":"Papalia","year":"2006","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.talanta.2016.07.022_bib54","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ab.2008.11.026","article-title":"Kinetic screening of antibody\u2013Im7 conjugates by capture on a colicin E7 DNase domain using optical biosensors","volume":"385","author":"Hosse","year":"2009","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.talanta.2016.07.022_bib55","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1124\/dmd.113.053793","article-title":"Pathway-dependent inhibition of paclitaxel hydroxylation by kinase inhibitors and assessment of drug-drug interaction potentials","volume":"42","author":"Wang","year":"2014","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.talanta.2016.07.022_bib56","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jchromb.2015.01.021","volume":"985","author":"Wang","year":"2015","journal-title":"J. Chromatogr. B"}],"container-title":["Talanta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039914016305148?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039914016305148?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T16:53:17Z","timestamp":1536598397000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039914016305148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":56,"alternative-id":["S0039914016305148"],"URL":"https:\/\/doi.org\/10.1016\/j.talanta.2016.07.022","relation":{},"ISSN":["0039-9140"],"issn-type":[{"type":"print","value":"0039-9140"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The development of a quantitative and qualitative method based on UHPLC-QTOF MS\/MS for evaluation paclitaxel\u2013tetrandrine interaction and its application to a pharmacokinetic study","name":"articletitle","label":"Article Title"},{"value":"Talanta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.talanta.2016.07.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}